# A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes Mellitus

> **NCT00282971** · PHASE3 · TERMINATED · sponsor: **Pfizer** · enrollment: 354 (actual)

## Conditions studied

- Diabetes Mellitus Type 2

## Interventions

- **DRUG:** Inhaled Insulin (Exubera)
- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT00282971
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-03-06
- **Primary completion:** 2008-02-19
- **Final completion:** 2008-02-19
- **Target enrollment:** 354 (ACTUAL)
- **Why stopped:** Terminated as marketing of this product will be discontinued
- **Last updated:** 2019-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00282971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00282971, "A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00282971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*